These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37848188)

  • 1. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
    Chen Y; Bei J; Chen M; Cai W; Zhou Z; Cai M; Huang W; Lin L; Guo Y; Liu M; Huang X; Xiao Z; Xu Z; Zhu K
    Adv Healthc Mater; 2024 Mar; 13(6):e2303031. PubMed ID: 37848188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma.
    Liu J; Li X; Chen J; Guo J; Guo H; Zhang X; Fan J; Zhang K; Mao J; Zhou B
    J Nanobiotechnology; 2024 Jun; 22(1):338. PubMed ID: 38890737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle Delivery of MnO
    Chang CC; Dinh TK; Lee YA; Wang FN; Sung YC; Yu PL; Chiu SC; Shih YC; Wu CY; Huang YD; Wang J; Lu TT; Wan D; Chen Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(40):44407-44419. PubMed ID: 32865389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel.
    Zhuang Q; Zhao B; Lin Z; Liang Y; Zhao Q; Wang Y; Liao N; Tu H; Zheng Y; Chen H; Zeng Y; Zhang D; Liu X
    Commun Biol; 2023 Jun; 6(1):621. PubMed ID: 37296221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photothermal MnO
    Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
    Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
    Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
    J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy.
    Zhou J; Hu Y; Cao Y; Ding S; Zeng L; Zhang Y; Cao M; Duan G; Zhang X; Bian XW; Tian G
    J Colloid Interface Sci; 2024 Apr; 660():869-884. PubMed ID: 38277843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-pronged microenvironmental modulation of metal-oxidase cascade catalysis and metabolic intervention for synergistic tumor immunotherapy.
    Song Q; Gao H; Sun S; Li Y; Wu X; Yang J; Wang B; Zhang Y; Wang L
    Acta Biomater; 2024 Jan; 173():378-388. PubMed ID: 37925121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma.
    Cheng Y; Gong Y; Chen X; Zhang Q; Zhang X; He Y; Pan L; Ni B; Yang F; Xu Y; Zhou L; Yang Y; Chen W
    Biomaterials; 2022 May; 284():121506. PubMed ID: 35390709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma.
    Zhang F; Liu W; Meng F; Jiang Q; Tang W; Liu Z; Lin X; Xue R; Zhang S; Dong L
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.
    Zhang J; Wei L; Ma X; Wang J; Liang S; Chen K; Wu M; Niu L; Zhang Y
    Acta Biomater; 2023 Aug; 166():470-484. PubMed ID: 37253416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for Enhanced Tumor Chemo-Immunotherapy.
    Li K; Lin C; He Y; Lu L; Xu K; Tao B; Xia Z; Zeng R; Mao Y; Luo Z; Cai K
    ACS Nano; 2020 Oct; 14(10):14164-14180. PubMed ID: 32975406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas.
    Luo L; Qiao H; Meng F; Dong X; Zhou B; Jiang H; Kanwar JR; Krissansen GW; Sun X
    Int J Cancer; 2006 Apr; 118(7):1823-30. PubMed ID: 16217749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice.
    Duan X; Wang M; Han X; Ren J; Huang G; Ju S; Zhang Q
    Cell Cycle; 2020 Dec; 19(24):3595-3607. PubMed ID: 33283623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
    Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
    Front Immunol; 2020; 11():1037. PubMed ID: 32547550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma.
    Lu YF; Zhou JP; Zhou QM; Yang XY; Wang XJ; Yu JN; Zhang JG; Du YZ; Yu RS
    J Nanobiotechnology; 2022 Jul; 20(1):351. PubMed ID: 35907841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomineralized MnO
    Deng Z; Xi M; Zhang C; Wu X; Li Q; Wang C; Fang H; Sun G; Zhang Y; Yang G; Liu Z
    ACS Nano; 2023 Mar; 17(5):4495-4506. PubMed ID: 36848115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.